George J. Kontoghiorghes
Postgraduate Research Institute of Science
Technology
Environment and Medicine
3 Ammochostou St
Cyprus
Name/email consistency: low
- Iron mobilization from transferrin and non-transferrin-bound-iron by deferiprone. Implications in the treatment of thalassemia, anemia of chronic disease, cancer and other conditions. Kontoghiorghes, G.J. Hemoglobin (2006)
- Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers. Kontoghiorghes, G.J. Hemoglobin (2006)
- Advances in iron overload therapies. prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NA11 and their combinations. Kontoghiorghes, G.J., Eracleous, E., Economides, C., Kolnagou, A. Curr. Med. Chem. (2005)
- Molecular factors and mechanisms affecting iron and other metal excretion or absorption in health and disease: the role of natural and synthetic chelators. Kontoghiorghes, G.J., Kolnagou, A. Curr. Med. Chem. (2005)
- The design and development of deferiprone (L1) and other iron chelators for clinical use: targeting methods and application prospects. Kontoghiorghes, G.J., Pattichis, K., Neocleous, K., Kolnagou, A. Curr. Med. Chem. (2004)
- Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine. Kontoghiorghes, G.J., Neocleous, K., Kolnagou, A. Drug. Saf (2003)
- Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1). Kontoghiorghes, G.J., Pattichi, K., Hadjigavriel, M., Kolnagou, A. Transfus. Sci (2000)
